GZMB and neoplasm: ILC1s express several molecules driving cytotoxicity including granzyme A, granzyme B, granzyme C, and TRAIL, and are highly efficient in killing tumor cells [51, 59–61] demonstrating a potent immunosurveillance and killing mechanism of ILCs.